Literature DB >> 29145012

The gut-brain interaction in opioid tolerance.

Hamid I Akbarali1, William L Dewey2.   

Abstract

The prevailing opioid crisis has necessitated the need to understand mechanisms leading to addiction and tolerance, the major contributors to overdose and death and to develop strategies for developing drugs for pain treatment that lack abuse liability and side-effects. Opioids are commonly used for treatment of pain and symptoms of inflammatory bowel disease. The significant effect of opioids in the gut, both acute and chronic, includes persistent constipation and paradoxically may also worsen pain symptoms. Recent work has suggested a significant role of the gastrointestinal microbiome in behavioral responses to opioids, including the development of tolerance to its pain-relieving effects. In this review, we present current concepts of gut-brain interaction in analgesic tolerance to opioids and suggest that peripheral mechanisms emanating from the gut can profoundly affect central control of opioid function.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29145012      PMCID: PMC5725258          DOI: 10.1016/j.coph.2017.10.012

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  38 in total

Review 1.  Mechanisms of fatal opioid overdose.

Authors:  J M White; R J Irvine
Journal:  Addiction       Date:  1999-07       Impact factor: 6.526

Review 2.  Incidence, prevalence, and management of opioid bowel dysfunction.

Authors:  M Pappagallo
Journal:  Am J Surg       Date:  2001-11       Impact factor: 2.565

3.  Avoiding the vicious cycle of prolonged opioid use in Crohn's disease.

Authors:  Jennifer L Jones; Edward V Loftus
Journal:  Am J Gastroenterol       Date:  2005-10       Impact factor: 10.864

4.  The role of β-arrestin2 in the mechanism of morphine tolerance in the mouse and guinea pig gastrointestinal tract.

Authors:  Minho Kang; Hercules T Maguma; Tricia H Smith; Gracious R Ross; William L Dewey; Hamid I Akbarali
Journal:  J Pharmacol Exp Ther       Date:  2011-11-30       Impact factor: 4.030

5.  Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis.

Authors:  C Acharya; N S Betrapally; P M Gillevet; R K Sterling; H Akbarali; M B White; D Ganapathy; A Fagan; M Sikaroodi; J S Bajaj
Journal:  Aliment Pharmacol Ther       Date:  2016-11-20       Impact factor: 8.171

Review 6.  Molecular mechanisms of opioid receptor-dependent signaling and behavior.

Authors:  Ream Al-Hasani; Michael R Bruchas
Journal:  Anesthesiology       Date:  2011-12       Impact factor: 7.892

Review 7.  The Microbiome and Host Behavior.

Authors:  Helen E Vuong; Jessica M Yano; Thomas C Fung; Elaine Y Hsiao
Journal:  Annu Rev Neurosci       Date:  2017-03-08       Impact factor: 12.449

8.  Morphine decreases enteric neuron excitability via inhibition of sodium channels.

Authors:  Tricia H Smith; John R Grider; William L Dewey; Hamid I Akbarali
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

9.  Loss of μ opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia.

Authors:  Gregory Corder; Vivianne L Tawfik; Dong Wang; Elizabeth I Sypek; Sarah A Low; Jasmine R Dickinson; Chaudy Sotoudeh; J David Clark; Ben A Barres; Christopher J Bohlen; Grégory Scherrer
Journal:  Nat Med       Date:  2017-01-16       Impact factor: 53.440

10.  Alterations of the Host Microbiome Affect Behavioral Responses to Cocaine.

Authors:  Drew D Kiraly; Deena M Walker; Erin S Calipari; Benoit Labonte; Orna Issler; Catherine J Pena; Efrain A Ribeiro; Scott J Russo; Eric J Nestler
Journal:  Sci Rep       Date:  2016-10-18       Impact factor: 4.379

View more
  15 in total

1.  C57BL/6 substrain differences in formalin-induced pain-like behavioral responses.

Authors:  Esad Ulker; Martial Caillaud; Trusha Patel; Alyssa White; Danyal Rashid; Mashael Alqasem; Aron H Lichtman; Camron D Bryant; M Imad Damaj
Journal:  Behav Brain Res       Date:  2020-05-16       Impact factor: 3.332

Review 2.  Gastrointestinal motility, dysbiosis and opioid-induced tolerance: is there a link?

Authors:  Hamid I Akbarali; William L Dewey
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-06       Impact factor: 46.802

3.  Evidence for Modulation of Substance Use Disorders by the Gut Microbiome: Hidden in Plain Sight.

Authors:  Mariana Angoa-Pérez; Donald M Kuhn
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

Review 4.  Role of microbes in the pathogenesis of neuropsychiatric disorders.

Authors:  Aranyak Goswami; Frank R Wendt; Gita A Pathak; Daniel S Tylee; Flavio De Angelis; Antonella De Lillo; Renato Polimanti
Journal:  Front Neuroendocrinol       Date:  2021-05-04       Impact factor: 8.333

Review 5.  Contributions of neuroimmune and gut-brain signaling to vulnerability of developing substance use disorders.

Authors:  Kelsey E Lucerne; Aya Osman; Katherine R Meckel; Drew D Kiraly
Journal:  Neuropharmacology       Date:  2021-05-06       Impact factor: 5.273

Review 6.  Gut-Brain Psychology: Rethinking Psychology From the Microbiota-Gut-Brain Axis.

Authors:  Shan Liang; Xiaoli Wu; Feng Jin
Journal:  Front Integr Neurosci       Date:  2018-09-11

Review 7.  The Microbiome and the Gut-Liver-Brain Axis for Central Nervous System Clinical Pharmacology: Challenges in Specifying and Integrating In Vitro and In Silico Models.

Authors:  Kyle G Hawkins; Caleb Casolaro; Jacquelyn A Brown; David A Edwards; John P Wikswo
Journal:  Clin Pharmacol Ther       Date:  2020-05-29       Impact factor: 6.875

Review 8.  Opioids and Sickle Cell Disease: From Opium to the Opioid Epidemic.

Authors:  Samir K Ballas
Journal:  J Clin Med       Date:  2021-01-23       Impact factor: 4.241

Review 9.  The role of the gut microbiome in opioid use.

Authors:  Michelle Ren; Shahrdad Lotfipour
Journal:  Behav Pharmacol       Date:  2020-04       Impact factor: 2.293

10.  How I Treat Acute and Persistent Sickle Cell Pain.

Authors:  Samir K Ballas
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-09-01       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.